CAS 1000403-03-1

INT-767

CAS: 1000403-03-1

INT-767

Purezza: ≥98%

Peso molecolare: 494.66g/mol

Ref: 54-BUP22011

INT-767

CAS: 1000403-03-1

INT-767 is a highly potent farneson X receptor (FXR)/TGR5 dual agonist that prevents NASH and promotes visceral fat brown lipogenesis and mitochondrial function

Formula: C₂₅H₄₃NaO₆S

Purezza: 98%

Colore e forma: Solid

Peso molecolare: 494.66

Ref: TM-T11661

INT-767

CAS: 1000403-03-1

INT-767 is a drug that inhibits the activity of toll-like receptor 4 (TLR4). It has been shown to inhibit the synthesis of collagen, which is an important component of fibrosis. INT-767 also counteracts some pharmacological treatments used in the treatment of metabolic disorders, such as diabetes and obesity. This drug selectively blocks TLR4 signaling pathways involved in inflammation, thereby inhibiting the production of cytokines and chemokines. INT-767 has been shown to reduce hepatic steatosis by reducing fat accumulation and decreasing levels of fatty acids in liver cells. In vitro studies have shown that INT-767 reduces cell proliferation and induces apoptosis by increasing expression of proteins involved in this process.

Formula: C₂₅H₄₃NaO₆S

Purezza: Min. 95%

Peso molecolare: 494.66 g/mol

Ref: 3D-AQB40303